Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 46 of 110 Updated Nov 17, 2026

Semax

ACTH(4-10) Pro-Gly-Pro analog

RUSSIA-APPROVED + ANECDOTAL · ACTH FRAGMENT ANALOG; NOOTROPIC

▓ 150 indexed citations across PubMed (141), EuropePMC (9).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

150 citations across 5 tiers

Tap any tier to jump to that section of the bibliography.

Background

Semax, an abbreviation of "seven amino acids", Russian: СЕМь АминоКиСлот) is a medication which is used in Eastern Europe for the treatment of a broad range of conditions like brain trauma but predominantly for its claimed nootropic, neuroprotective, and neurorestorative effects.

→ Wikipedia

Mechanism of action

Upregulates BDNF and NGF; modulates dopamine and serotonin systems; neuroprotective

Researched effects

Enhanced focus and memory; BDNF elevation; neuroprotection; stroke recovery (Russia-approved)

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

200 mcg intranasal daily (0.1% solution, 2-3 drops per nostril, nootropic starting dose, max 600 mcg/day per Russian clinical literature for stroke and cognitive support)

→ Kaplan AY/Myasoedov NF Russian neuroprotection trials (Semax indications); r/Peptides wiki nootropic dosing consensus

Known concerns

Mild irritability; insomnia; nasal irritation with intranasal use

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2007 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.7

  2. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018 — CLINICAL TRIALS · AUTHORITY 68.8

  3. [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease].

    Vestnik oftalmologii · 2000 — CLINICAL TRIALS · AUTHORITY 67.0

  4. [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 1997 — CLINICAL TRIALS · AUTHORITY 67.0

  5. Pharmacological Aspects of Neuro-Immune Interactions.

    Current pharmaceutical design · 2018 — REVIEWS · AUTHORITY 53.8

  6. [POSSIBLE ROLE OF TRANSTHYRETIN IN THE BIOLOGICAL MECHANISM OF THE REGULATORY PEPTIDE NEUROPROTECTION.].

    Molekuliarnaia genetika, mikrobiologiia i virusologiia · 2016 — REVIEWS · AUTHORITY 53.6

  7. Sigmoidal maximal effect modeling of low-density lipoprotein cholesterol concentration and annual incidence of coronary heart disease events in secondary prevention trials.

    Pharmacotherapy · 2014 — REVIEWS · AUTHORITY 53.4

  8. [Neuroprotective effects of peptides bioregulators in people of various age].

    Advances in gerontology = Uspekhi gerontologii · 2013 — REVIEWS · AUTHORITY 53.3

  9. [Neonatal injections of pharmacological agents and their remote genotype-dependent effects in mice and rats].

    Ontogenez · 2012 — REVIEWS · AUTHORITY 53.2

  10. [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].

    Izvestiia Akademii nauk. Seriia biologicheskaia · 2006 — REVIEWS · AUTHORITY 52.6

Full citation library

Year distribution

Randomised Controlled Trials

1
  1. 1.

    Serdiuk AV, Levitskiĭ GN, Miasoedov NF, Skvortsova VI · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2007 · PMID 18379501

    The study of chronic partial denervation (CPD) and quality of life was carried out in 27 patients with definite, probable and possible diagnosis of motor neuron disease (MND) treated with semax (1% solution). The needle electromyography (EMG) was performed thrice with short-term 2 month interval (60 days before enrollment and on day 1 and day 48 of the study) in three muscles on bulbar, cervical and lumbosacral levels on the less affected side. According to Revised El-Escorial Criteria (1998) th…

Clinical Trials

3
  1. 2.

    Gusev EI, Martynov MY, Kostenko EV, Petrova LV, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2018 · PMID 29798983

    To evaluate the efficacy of semax and timing of rehabilitation on the dynamics of plasma BDNF levels, motor performance, and Barthel index score in patients after ischemic stroke (IS). One hundred and ten patients after IS (43 men, 67 women, mean age 58.0±9.7, Ме 63 years) were examined. All patients were divided into early (89±9 days) and late (214±22 days) rehabilitation groups. Each group was subdivided into semax+ and semax- subgroups. Standard regimen of semax included 2 courses (6000 mcg/d…

  2. 3.

    Gusev EI, Skvortsova VI, Miasoedov NF, Nezavibat'ko VN, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 1997 · PMID 11517472

    Efficiency of Semax (synthetic derivative of ACTH-4-10) was studied in 30 patients in acute period of hemispherical ischemic stroke. Control group consisted of 80 patients with the strokes analogous in severity and location of the damages and which were treated by conventional therapy. Different clinical rating scales were used for both objectivization of the severity of the patients' state and estimation of the degree of neurological defect. The control of Semax influence on the functional stat…

  3. 4.

    Polunin GS, Nurieva SM, Baiandin DL, Sheremet NL, et al. · Vestnik oftalmologii · 2000 · PMID 10741256

    Semax is a synthetic analog of adrenocorticotropic hormone 4-10 with a pronounced nootropic effect. It was used in the treatment of vascular, toxic allergic, and inflammatory diseases of the optic nerve and partial atrophy of the optic nerve in parallel with basic neurotrophic and antiinflammatory therapy. For evaluating the drug efficiency, the patients were divided into 3 groups, administered the drug via different routes. In group 1 semax was administered intransally as nasal drops, in group…

Reviews

7
  1. 5.

    Tarasov VV, Kudryashov NV, Chubarev VN, Kalinina TS, et al. · Current pharmaceutical design · 2018 · PMID 28875850

    The use of systematic approach for the analysis of mechanism of action of drugs at different levels of biological organization of organisms is an important task in experimental and clinical pharmacology for drug designing and increasing the efficacy and safety of drugs. The analysis of published data on pharmacological effects of psychotropic drugs possessing immunomodulatory and/or antiviral properties have shown a correlation between central effects of examined drugs associated with the impact…

  2. 6.

    Vyunova TV, Medvedeva EV, Andreeva LA, Dergunova LV, et al. · Molekuliarnaia genetika, mikrobiologiia i virusologiia · 2016 · PMID 30383932

    The peptide preparation Semax has been effectively used for therapy of ischemic stroke. However, the mechanisms of its action are insufficiently understood and actively studied. The full-genome analysis of the transcriptome implemented in our recent work dem- onstrated that under conditions of focal ischemia of rat brain the Semax modified the profile of the transcription activity of many genes. In this case, the difference in the transcription levels of the gene encoding the protein transthyret…

  3. 7.

    Charland SL, Stanek EJ · Pharmacotherapy · 2014 · PMID 24877185

    To evaluate the relationship between low-density lipoprotein cholesterol (LDL-C) concentration and the annual incidence of combined coronary heart disease (CHD) events—death or nonfatal myocardial infarction (NFMI)—by using sigmoidal maximal effect (sEmax) modeling of published data in various populations at risk for CHD events, and to use the best performing sEmax model generated to calculate the number needed to treat (NNT) to prevent a single CHD death or NFMI event across a range of LDL-C co…

  4. 8.

    Liapina LA, Pastorova VE, Obergan TIu, Samonina GE, et al. · Izvestiia Akademii nauk. Seriia biologicheskaia · 2006 · PMID 16634437

    Experimental and theoretical demonstration of different effect of certain regulatory peptides (RPs) on blood coagulation is available. The problem of the role of RPs in hemostatic processes becomes particularly significant since, first, the peptides are widespread in nature both in animal and plant tissues, second, there is a relationship between the peptide structure and function and, third, both natural and synthetic peptides are used in practical medicine to correct functions of some factors…

  5. 9.

    Poletaeva II, Perepelkina OV, Boiarshinova OS, Lil'p IG, et al. · Ontogenez · 2012 · PMID 23401956

    Experimental data were reviewed which demonstrated that the neonatal injection effects of certain biologically active drugs (ACTH(4-10) fragment and its analogue Semax, piracetam, caffeine, levetiracetam, busperone, etc.) could be detected in adult animals as changes in physiological and behavioral reactions and in several morphological traits as well. Audiogenic seizures proneness, anxiety-fear and exploration behavior as well as pain sensitivity were analyzed. The remote effects discovered wer…

  6. 10.

    Mavrych V, Shypilova I, Bolgova O · Frontiers in aging · 2026 · PMID 42021992

    Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline. To comprehensively review the mechanisms, clinical applications, evidence base, and safety profiles of therapeutic peptides with demonstrated or potential applications in healthy aging and age-related conditions. A comprehensive narrative review was conducted through systematic…

  7. 11.

    Umnov RS, Lin'kova NS, Khavinson VKh · Advances in gerontology = Uspekhi gerontologii · 2013 · PMID 24738258

    The review presents comparative characteristics of 2 peptide neuroprotective groups: polypeptide complexes (cortexin, cerebrolizin) and short peptides (semax, kortagen, pinealon). The data of clinical applying of peptides in elderly and old age people and cellular and molecular mechanisms of their neuroprotective activity is described.

Research Articles

136
  1. 12.

    Liu R, Chen Y, Huang H, Li X, et al. · British journal of pharmacology · 2025 · PMID 40692165

    Lysosomal membrane permeabilization (LMP) is exacerbated following spinal cord injury (SCI), leading to increased neuronal cell death. Ubiquitination may affect LMP by regulating the stability and functionality of lysosomal membranes. Semax, a synthetic heptapeptide, comprising the ACTH (4-7) fragment and a C-terminal Pro-Gly-Pro tripeptide, exhibits neuroprotective properties and improves cognitive function. Given the key roles of LMP and ubiquitination in SCI pathophysiology, this study invest…

  2. 13.

    Filippenkov IB, Shpetko YY, Stavchansky VV, Denisova AE, et al. · Biomedicines · 2024 · PMID 39767736

  3. 14.

    Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF · Journal of molecular recognition : JMR · 2017 · PMID 27921334

    Short endogenous peptides represent one of the most important constituents of the mammalian body's general regulatory system. Some synthesized analogs and modified natural peptides (eg, corticotropins) also show high biological activity. Nevertheless, the mechanism of action of regulatory peptides remains unclear. To explain the effects of peptides of intermolecular processes, the hypothesis that a synactonal mechanism underlies the action of regulatory peptides, exemplified by the heptapeptide…

  4. 15.

    Medvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, et al. · BMC genomics · 2014 · PMID 24661604

    The nootropic neuroprotective peptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) has proved efficient in the therapy of brain stroke; however, the molecular mechanisms underlying its action remain obscure. Our genome-wide study was designed to investigate the response of the transcriptome of ischemized rat brain cortex tissues to the action of Semax in vivo. The gene-expression alteration caused by the action of the peptide Semax was compared with the gene expression of the "ischemia" group animals at…

  5. 16.

    Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, et al. · Journal of neurochemistry · 2006 · PMID 16635254

    The heptapeptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an analogue of the N-terminal fragment (4-10) of adrenocorticotropic hormone which, after intranasal application, has profound effects on learning and memory formation in rodents and humans, and also exerts marked neuroprotective effects. A clue to the molecular mechanism underlying this neurotropic action was recently given by the observation that Semax stimulates the synthesis of brain-derived neurotrophic factor (BDNF), a potent modulato…

  6. 17.

    Magrì A, Tabbì G, Giuffrida A, Pappalardo G, et al. · Journal of inorganic biochemistry · 2016 · PMID 27586814

    Semax is a heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) that encompasses the sequence 4-7 of N-terminal domain of the adrenocorticotropic hormone and a C-terminal Pro-Gly-Pro tripeptide. N-terminal amino group acetylation (Ac-Semax) modulates the chemical and biological properties of parental peptide, modifying the ability of Semax to form complex species with Cu(II) ion. At physiological pH, the main complex species formed by Ac-Semax, [CuLH

  7. 18.

    Eremin KO, Kudrin VS, Saransaari P, Oja SS, et al. · Neurochemical research · 2005 · PMID 16362768

    Corticotrophin (ACTH) and its analogues, particularly Semax (Met-Glu-His-Phe-Pro-Gly-Pro), demonstrate nootropic activity. Close functional and anatomical links have been established between melanocortinergic and monoaminergic brain systems. The aim of present work was to investigate the effects of Semax on neurochemical parameters of dopaminergic- and serotonergic systems in rodents. The tissue content of 5-hydroxyindoleacetic acid (5-HIAA) in the striatum was significantly increased (+25%) 2 h…

  8. 19.

    Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, et al. · Cellular and molecular neurobiology · 2010 · PMID 19633950

    Consisting of a fragment of ACTH(4-7) and C-terminal PGP tripeptide, the polypeptide Semax is successfully used for acute stroke therapy. Previous experiments showed rapid induction of Bdnf, Ngf, and TrkB expression in intact rat hippocampus following Semax treatment. To investigate the mRNA expression of neurotrophins and their receptors after treatment with either Semax or PGP, the rat brains were analyzed at three time points following a permanent middle cerebral artery occlusion (pMCAO). We…

  9. 20.

    Manchenko DM, Glazova NIu, Levitskaia NG, Andreeva LA, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2010 · PMID 21268834

    Heptapeptide Semax (MEHFPGP) is the fragment of ACTH(4-10) analogue with prolonged neurotropic activity. The aim of the present work was to study the Semax effects on learning capability and pain sensitivity in white rats following intraperitoneal and intranasal administration in different doses. Semax nootropic effects were studied in the test of acquisition of passive avoidance task. Pain sensitivity was estimated in Randall-Selitto paw-withdrawal test. It was shown that Semax exerts nootropic…

  10. 21.

    Stavchansky VV, Filippenkov IB, Remizova JA, Denisova AE, et al. · Genes · 2022 · PMID 36553646

    Glyprolines are Gly-Pro (GP)- or Pro-Gly (PG)-containing biogenic peptides. These peptides can act as neutrophil chemoattractants, or atheroprotective, anticoagulant, and neuroprotective agents. The Pro-Gly-Pro (PGP) tripeptide is an active factor of resistance to the biodegradation of peptide drugs. The synthetic Semax peptide, which includes Met-Glu-His-Phe (MEHF) fragments of adrenocorticotropic hormone and the C-terminal tripeptide PGP, serves as a neuroprotective drug for the treatment of i…

  11. 22.

    Glazova NY, Manchenko DM, Volodina MA, Merchieva SA, et al. · Neuropeptides · 2021 · PMID 33418449

    Selective serotonin reuptake inhibitors (SSRI) are commonly used to treat depression during pregnancy. SSRIs cross the placenta and may influence the maturation of the foetal brain. Clinical and preclinical findings suggest long-term consequences of SSRI perinatal exposure for the offspring. The mechanisms of SSRI effects on developing brain remain largely unknown and there are no directional approaches for prevention of the consequences of maternal SSRI treatment during pregnancy. The heptapept…

  12. 23.

    Filippenkov IB, Shpetko YY, Ales DA, Stavchansky VV, et al. · International journal of molecular sciences · 2025 · PMID 40650034

    In the treatment of ischemic stroke, an innovative approach is the use of neuroprotective compounds. Natural peptides, including adrenocorticotropic hormone (ACTH), can serve as the basis for such drugs. Previously, a significant effect of non-hormonal ACTH(4-7)PGP (Semax) and ACTH(6-9)PGP peptides on the functions of the nervous system was shown. Also, while using RNA-Seq, we firstly revealed differentially expressed genes (DEGs) that associated with peptides in the penumbra-associated region o…

  13. 24.

    Agapova TY, Agniullin YV, Shadrina MI, Shram SI, et al. · Neuroscience letters · 2007 · PMID 17353092

    The heptapeptide Semax, an analogue of the N-terminal adrenocorticotropic hormone fragment (4-10) (ACTH(4-10)), has been shown to exert a number of neuroprotective effects. There are some investigations that connected these effects with the increase of neurotrophin gene expression under the peptide drug application in neuron cell cultures [M.I. Shadrina, O.V. Dolotov, I.A. Grivennikov, P.A. Slominsky, L.A. Andreeva, L.S. Inozemtseva, S.A. Limborska, N.F. Myasoedov, Rapid induction of neurotrophi…

  14. 25.

    Lebedeva IS, Panikratova YR, Sokolov OY, Kupriyanov DA, et al. · Bulletin of experimental biology and medicine · 2018 · PMID 30225715

    The effects of nootropic drug Semax on the neuronal network of the brain were studied by the resting state functional magnetic-resonance imaging (resting state fMRI). The study was carried out on two groups of healthy volunteers (11 men and 13 women aged 43.9±9.5 years). Resting state fMRI was carried out 3 times: directly before and 5 and 20 min after intranasal 1% Semax (14 subjects) or placebo (10 subjects). The topography of the resting state default mode network was studied. A greater volum…

  15. 26.

    Grivennikov IA, Dolotov OV, Zolotarev YA, Andreeva LA, et al. · Restorative neurology and neuroscience · 2008 · PMID 18431004

    It is well established that cholinergic neurons of the basal forebrain degenerate in Alzheimer's dementia. Although recent studies were concentrated on screening molecules that might reduce the concomitant cell loss, little is known about therapeutically promising molecules. We studied the effect of Semax (Met-Glu-His-Phe-Pro-Gly-Pro), a behaviorally active adrenocorticotropic hormone (4-10) analogue, on survival of cholinergic basal forebrain neurons in vitro. Semax is known to stimulate learni…

  16. 27.

    Medvedeva EV, Dmitrieva VG, Limborska SA, Myasoedov NF, et al. · Molecular genetics and genomics : MGG · 2017 · PMID 28255762

    Brain stroke continues to claim the lives of million people every year. To build the effective strategies for stroke treatment it is necessary to understand the neuroprotective mechanisms that are able to prevent the ischemic injury. Consisting of the ACTH

  17. 28.

    Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020 · PMID 32342318

    The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants. The ROIs included amygdala (one of the key regions for the regulation of anxiety) and dorsolateral prefrontal cortex (DLPFC; the key region for executive functions, including working memory) in the right and left hemisphere. Resting-state fMRI was carried out…

  18. 29.

    Sudarkina OY, Filippenkov IB, Stavchansky VV, Denisova AE, et al. · International journal of molecular sciences · 2021 · PMID 34201112

    The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide enhanced the transcription of neurotrophins and their receptors and modulated the expression of genes involved in the immune response. A genome-wide RNA-Seq analysis revealed that, in the rat transient middle cerebral…

  19. 30.

    Filippenkov IB, Stavchansky VV, Denisova AE, Yuzhakov VV, et al. · Genes · 2020 · PMID 32580520

    Cerebral ischaemia is the most common cause of impaired brain function. Biologically active peptides represent potential drugs for reducing the damage that occurs after ischaemia. The synthetic melanocortin derivative, ACTH

  20. 31.

    Dergunova LV, Dmitrieva VG, Filippenkov IB, Stavchansky VV, et al. · Molekuliarnaia biologiia · 2021 · PMID 34097675

    Due to its nootropic, neuroprotective, and immunomodulatory effects, the peptide Semax is utilized in the treatment of ischemic stroke. Our earlier RNA-Seq analysis of the transcriptome in an ischemic model of transient occlusion of the middle cerebral artery showed an increase in the mRNA levels of many proinflammatory genes, and the suppression of their induction by Semax. However, for many relevant genes, including Il1a, Il1b, Il6 and Tnfa, the levels of their expression were too low for deta…

  21. 32.

    Shadrina M, Kolomin T, Agapova T, Agniullin Y, et al. · Journal of molecular neuroscience : MN · 2010 · PMID 19662538

    Neurotrophins are a family of structurally related proteins that regulate the survival, differentiation, and maintenance of function of different neuron populations. Some peptides are able to affect the production and activity of neurotrophins. One of these synthetic peptides is heptapeptide Semax, an analog of the N-terminal adrenocorticotropic hormone fragment 4-10. It is known that Semax has effects on learning and memory formation and exerts some neuroprotective effects in rodents and humans…

  22. 33.

    Vyunova TV, Andreeva LA, Shevchenko KV, Glazova NY, et al. · Chemical biology & drug design · 2023 · PMID 36828803

    The central effectors of the stress system are greatly interconnected and include, among others, a large group of peptides derived from proopiomelanocortin. In addition to natural corticotropins, a number of artificial molecules that contain some ACTH fragments in their structure are also referred to members of this family. Some of them possess a wide range of biological activity. The molecular mechanism underlying the biological activity of such peptides is partly based on allosteric modulation…

  23. 34.

    Inozemtsev AN, Bokieva SB, Karpukhina OV, Gumargalieva KZ, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2016 · PMID 27411820

    Separate and joint effect of Semax, ascorbic acid, lead diacetate, and ammonium molybdate on avoidance conditioning in rats was studied. It was established that the heavy metal salts inhibited the avoidance response, and the peptide counteracted this inhibition as strongly as ascorbic acid or to a comparable degree. These findings confirm the antioxidant properties of Semax.

  24. 35.

    Tomasello MF, Di Rosa MC, Naletova I, Sciacca MFM, et al. · Bioinorganic chemistry and applications · 2025 · PMID 40496623

    Alzheimer's disease (AD) is the most common neurodegenerative disorder associated with cognitive decline and loss of memory. It is postulated that the generation of reactive oxygen species (ROS) in Fenton-like reaction connected with Cu(II)/Cu(I) redox cycling of the Cu(II)-aβ complex can play a key role in the molecular mechanism of neurotoxicity in AD. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic regulatory peptide that possesses a high affinity for Cu(II) ions. The ability of the peptid…

  25. 36.

    Sebentsova EA, Levitskaya NG, Andreeva LA, Alfeeva LY, et al. · Bulletin of experimental biology and medicine · 2006 · PMID 16984088

    We studied the neurotropic effects of ACTH(4-10) analog semax against the background of dopaminergic receptors blockade with haloperidol. Intranasal administration of semax (0.05, 0.2, and 0.6 mg/kg) produced virtually no effect on disturbances of orientation and exploratory reactions and motor activity caused by intraperitoneal injection of 0.2 mg/kg haloperidol. By contrast, preliminary administration of 0.05 mg/kg semax prevented haloperidol-induced disturbances in active avoidance conditioni…

  26. 37.

    Torshin IY, Gromova OA, Sardaryan IS, Fedotova LE · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2017 · PMID 28514338

    To compare mexidol with control molecules (choline alfoscerate, piracetam, glycine, semax) using chemoreactome analysis. The chemical structure of mexidol was compared to molecule metabolites extracted from the Human Metabolome Database (HMDB) and a drug database. More than 40 000 of metabolites from HMDB were used as a model of human metabolome. The chemoreactome analysis showed that mexidol may be (1) an agonist of acetylcholine and GABA-A receptors; (2) an anti-inflammatory agent, the effects…

  27. 38.

    Sciacca MFM, Naletova I, Giuffrida ML, Attanasio F · ACS chemical neuroscience · 2022 · PMID 35080861

    Alzheimer's disease, the most common form of dementia, is characterized by the aggregation of amyloid beta protein (Aβ). The aggregation and toxicity of Aβ are strongly modulated by metal ions and phospholipidic membranes. In particular, Cu

  28. 39.

    Tsai SJ · Medical hypotheses · 2007 · PMID 16996699

    Psychostimulants, such as methylphenidate, are currently the most common used drug therapy for children with attention-deficit hyperactivity disorder (ADHD). However, a number of patients with ADHD either fail to respond to these drugs or experience side effects that preclude their use. The heptapeptide Semax is an analogue of the N-terminal fragment (4-10) of adrenocorticotropic hormone, but is completely devoid of any hormonal activity. It has been found to stimulate memory and attention in ro…

  29. 40.

    Sheremet NL, Polunin GS, Ovchinnikov AN, Kamenskiĭ AA, et al. · Vestnik oftalmologii · 2004 · PMID 15678666

    In order to substantiate the feasibility of using the "Semax" neuroprotector in the treatment of optic-nerve diseases its pharmacokinetics in the intranasal administration was studied in experiments with rats; besides, the physical-and-chemical properties of "Semax" were investigated to define the preparation's stability and mobility in the electric field. A series of experiments, involving a tritium-marked "Semax", showed that the peptide actively penetrates into the brain and eyes of experimen…

  30. 41.

    Shevchenko KV, Nagaev IY, Andreeva LA, Shevchenko VP, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2013 · PMID 23652441

  31. 42.

    Eremin KO, Kudrin VS, Grivennikov IA, Miasoedov NF, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2004 · PMID 15088389

  32. 43.

    Malyshev AV, Razumkina EV, Dubynin VA, Myasoedov NF · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2013 · PMID 23821048

  33. 44.

    V'yunova TV, Shevchenko KV, Shevchenko VP, Bobrov MY, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2006 · PMID 17278839

  34. 45.

    Yatsenko KA, Glazova NY, Inozemtseva LS, Andreeva LA, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2013 · PMID 24385169

  35. 46.

    Romanova GA, Silachev DN, Shakova FM, Kvashennikova YN, et al. · Bulletin of experimental biology and medicine · 2006 · PMID 17603664

    Semax had a pronounced neuroprotective and antiamnesic effect during focal photoinduced ischemia of the prefrontal cortex. Intranasal administration of Semax for 6 days decreased the volume of cortical infarction and improved retention and performance of conditioned passive avoidance response.

  36. 47.

    Levitskaya NG, Sebentsova EA, Andreeva LA, Alfeeva LY, et al. · Neuroscience and behavioral physiology · 2004 · PMID 15341218

    This report describes studies cf the effects of the ACTH(4-10) analog Semax (MEHFPGP) on the behavior of white rats with lesions to the brain dopaminergic system induced by the neurotoxin MPTP. Neurotoxin was given as single i.p. doses of 25 mg/kg. Neurotoxin injections were shown to decrease movement activity and increase anxiety in the animals. Daily intranasal administration of Semax at a dose of 0.2 mg/kg decreased the severity of MPTP-induced behavioral disturbances. The protective activity…

  37. 48.

    Filippenkov IB, Remizova JA, Stavchansky VV, Denisova AE, et al. · Genes · 2023 · PMID 37510287

    Ischemic stroke is an acute local decrease in cerebral blood flow due to a thrombus or embolus. Of particular importance is the study of the genetic systems that determine the mechanisms underlying the formation and maintenance of a therapeutic window (a time interval of up to 6 h after a stroke) when effective treatment can be provided. Here, we used a transient middle cerebral artery occlusion (tMCAO) model in rats to study two synthetic derivatives of adrenocorticotropic hormone (ACTH). The f…

  38. 49.

    Vyunova TV, Andreeva LA, Shevchenko KV, Myasoedov NF · Journal of labelled compounds & radiopharmaceuticals · 2019 · PMID 31325343

    An integrated methodological approach to study the molecular aspects of short regulatory neuropeptides biological mechanism is proposed. The complex research is based on radioligand-receptor method of analysis and covers such points of peptides molecular activity as: specific binding of peptides to brain cells plasmatic membranes, formation of tissue specific synacton, influence of peptides (as allosteric modulators) on functionality of different neuroreceptors as well as delayed in time effects…

  39. 50.

    Volodina MA, Sebentsova EA, Glazova NY, Levitskaya NG, et al. · Bulletin of experimental biology and medicine · 2012 · PMID 22803132

    Maternal deprivation in the early postnatal period significantly affects the behavior and development of different animals. Here we studied delayed effects of daily maternal deprivation (5 h/day) on physical development and behavior of white rats during postnatal days 1 to 14. Here we studied the possibility of reducing the negative consequences of deprivation by daily intranasal treatment with Semax, an analog of ACTH(4-10), in a dose of 0.05 mg/kg from postnatal days 15 to 28. It was found tha…

  40. 51.

    Dolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, et al. · Brain research · 2006 · PMID 16996037

    The heptapeptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is an analog of the adrenocorticotropin fragment (4-10) which after intranasal application has profound effects on learning and exerts marked neuroprotective activities. Here, we found that a single application of Semax (50 microg/kg body weight) results in a maximal 1.4-fold increase of BDNF protein levels accompanying with 1.6-fold increase of trkB tyrosine phosporylation levels, and a 3-fold and a 2-fold increase of exon III BDNF and trkB m…

  41. 52.

    Dolotov OV, Seredenina TS, Levitskaya NG, Kamensky AA, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2003 · PMID 14556513

  42. 53.

    Sharonova IN, Bukanova YV, Myasoedov NF, Skrebitskii VG · Bulletin of experimental biology and medicine · 2018 · PMID 29577196

    The concentration-clamp experiments with neurons isolated from the rat brain showed that nootropic and neuroprotective drug Semax added to perfusion solution at concentration of 1 μM augmented the amplitude of GABA-activated ionic currents in cerebellum Purkinje cells by 147±13%. In addition, Semax in perfusion solution (0.1 and 1 μM) diminished the amplitude of glycine-activated chloride currents in hippocampal pyramidal neurons down to 68 and 43% control level, respectively. Both potentiating…

  43. 54.

    Inozemtseva LS, Yatsenko KA, Glazova NY, Kamensky AA, et al. · European journal of pharmacology · 2024 · PMID 39442746

    Current antidepressant therapy shows substantial limitations, and there is an urgent need for the development of new treatment strategies for depression. Stressful events and hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis play an important role in the pathogenesis of depression. HPA axis activity is self-regulated by negative feedback at several levels including adrenocorticotropic hormone (ACTH)-mediated feedback. Here, we investigated whether noncorticotropic synthetic analogs…

  44. 55.

    Elagina AA, Lyashev YD, Lyashev AY, Pronyaeva TV, et al. · Bulletin of experimental biology and medicine · 2020 · PMID 32246363

    We studied the effect of peptide drugs deltalicin and Semax on lipid metabolism disturbances in diabetes mellitus. Diabetes mellitus was modeled by single injection of streptozotocin (45 mg/kg) and rats with blood glucose ≥12 mmol/liter were selected for the further experiments. Deltalicin in a dose 100 μg/kg and Semax in a dose 200 μg/kg as well as sulodexide corrected lipid metabolism disorders: the content of total cholesterol, triglycerides, LDL, index of atherogenicity decreased and HDL con…

  45. 56.

    Svishcheva MV, Mukhina AY, Medvedeva OA, Shevchenko AV, et al. · Bulletin of experimental biology and medicine · 2020 · PMID 32737723

    We studied the effect of Semax on the state of intestinal microbiota in rats subjected to restraint stress. Semax was injected to Wistar male rats intraperitoneally in doses of 5, 50, 150, 450 μg/kg 12-15 min before modelling chronic restraint stress. It was found that stress exposure reduced the number of obligate bacteria in the colon microbiota, but increased the content of opportunistic microorganisms. Semax in doses of 50 and 150 μg/kg prevented the stress-induced changes in the composition…

  46. 57.

    Pae CU · CNS spectrums · 2008 · PMID 18204410

  47. 58.

    Shevchenko KV, Nagaev IIu, Alfeeva LIu, Andreeva LA, et al. · Bioorganicheskaia khimiia · 2006 · PMID 16523722

    The radioactive peptide analogue Semax corresponding to the ACTH(4-10) sequence (Met-Glu-His-Phe-Pro-Gly-Pro) with a molar radioactivity of 56 Ci/mmol labeled with tritium at the C-terminal Pro was prepared. The labeled peptide was used for studying the kinetics of Semax penetration into rat brain and blood after its intranasal administration (50 microg/kg, 20 microl of solution) to nonbred white rats of body mass 200-250 g. It was demonstrated that 0.093% of the total introduced radioactivity p…

  48. 59.

    Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, et al. · Bioorganicheskaia khimiia · 2001 · PMID 11443939

    A dose-dependent effect of synthetic heptapeptides Semax (Met-Glu-His-Phe-Pro-Gly-Pro) and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on the enkephalin-degrading enzymes of human serum was demonstrated. The inhibitory effects of Semax (IC50 10 microM) and Selank (IC50 20 microM) are more pronounced than those of puromycin (IC50 10 mM), bacitracin, and some other inhibitors of peptidases. Beside the heptapeptides, their pentapeptide fragments also possessed an inhibitory effect; tri-, tetra-, and hexap…

  49. 60.

    Inozemtsev AN, Agapitova AE, Bokieva SB, Glazova NIu, et al. · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2013 · PMID 25464761

    Semax effects on formation of active avoidance reaction in rats in different experimental models have been studied. It was shown that intraperitoneal Semax administration at a dose of 0.05 mg/kg accelerated acquisition of one-way active avoidance response when rats were trained to avoid electric foot-shock by jumping on the shelf. When rats were trained in shuttle-box the peptide increased the electroshock threshold value required to provocation of rat moving in experimental box and delayed acqu…

  50. 61.

    Kolbaev SN, Sharonova IN, Skrebitsky VG · Bulletin of experimental biology and medicine · 2025 · PMID 41171324

    We studied the effects of Semax on spontaneous fluctuations of intracellular calcium ion concentration [Ca

  51. 62.

    Samotrueva MA, Yasenyavskaya AL, Murtalieva VK, Bashkina OA, et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31028579

    We studied immunocorrecting effects of Semax (Met-Glu-His-Phe-Pro-Gly-Pro) on the model of "social" stress caused by sensory contact and intermale confrontation. Functional activity of the immune system of laboratory animals was evaluated in standard immunopharmacological tests: delayed-type hypersensitivity reaction, direct agglutination test, latex test for studying phagocytic activity of peripheral blood neutrophils, changes in differential leukocyte count, and weight of immunocompetent organ…

  52. 63.

    Slominsky PA, Shadrina MI, Kolomin TA, Stavrovskaya AV, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2017 · PMID 28702721

    Parkinson's disease (PD) is the second most common severe neurodegenerative disorder that is characterized by progressive degeneration of dopaminergic neurons (DA neurons) in the substantia nigra pars compacta (SNpc) region of the brain. In the present study, we investigated the effects of the synthetic regulatory peptides Semax (analog of an ACTH 4-10 fragment (ACTH4-10)) and Selank (analog of immunomodulatory taftsin) on behavior of rats with 6-hydroxidopamine (6-OHDA) induced PD-like parkinso…

  53. 64.

    Iasnetsov VV, Voronina TA · Eksperimental'naia i klinicheskaia farmakologiia · 2010 · PMID 20486550

    Upon single administration, mexidol and semax only in doses of 100 and 0.05 mg/kg, respectively, produced an antihypoxic effect on mice in the altitude chamber and hermetic chamber tests. Preventive course administration of mexidol and semax for 6 days gave significant antihypoxic effect on the model of acute hypobaric hypoxia in mice in doses of 75 and 0.1 mg/kg per day, respectively, in which the same preparations upon single administration were ineffective. Neither mexidol nor semax upon sing…

  54. 65.

    Levitskaya NG, Sebentsova EA, Glazova NYu, Voskresenskaya OG, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2000 · PMID 10944712

  55. 66.

    Ivanova DM, Levitskaya NG, Andreeva LA, Kamenskii AA, et al. · Bulletin of experimental biology and medicine · 2007 · PMID 18018999

    The effects of ACTH4-10 fragment and its analog semax on nociception were examined on various animal models. ACTH4-10 in a dose of 0.5 mg/kg decreased nociception in rats during hindpaw compression test and in mice subjected to acetic acid writhing test. Lower doses of ACTH4-10 produced no analgesic effect. Semax (0.015-0.500 mg/kg) decreased pain sensitivity in all experimental models. Hence, the substitution of three C-terminal amino acid residues in ACTH4-10 for Pro-Gly-Pro sequence augmented…

  56. 67.

    Stavchansky VV, Yuzhakov VV, Botsina AY, Skvortsova VI, et al. · Journal of molecular neuroscience : MN · 2011 · PMID 20617398

    The neuropeptide preparation Semax (Met-Glu-His-Phe-Pro-Gly-Pro) has been employed successfully in clinical practice for treating patients with severe brain blood circulation disorders. In spite of numerous studies, many aspects of the therapeutic effects of this preparation remain unknown. In this context, the effects of Semax and its C-end tripeptide PGP on the functional morphology of nervous tissue cells were studied in the normal rat brain and in a model of incomplete global rat brain ische…

  57. 68.

    Tabbì G, Magrì A, Giuffrida A, Lanza V, et al. · Journal of inorganic biochemistry · 2015 · PMID 25310602

    Heptapeptide Semax, encompassing the sequence 4-7 of N-terminal domain of the adrenocorticotropic hormone (ACTH) and a C-terminal Pro-Gly-Pro tripeptide, belongs to a short regulatory peptides family. This compound has been found to affect learning processes and to exert marked neuroprotective activities on cognitive brain functions. Dys-homeostasis of metal ions is involved in several neurodegenerative disorders and growing evidences have showed that brain is a specialized organ able to concent…

  58. 69.

    Filippenkov IB, Glazova NY, Sebentsova EA, Stavchansky VV, et al. · Biochemistry. Biokhimiia · 2024 · PMID 39418522

    Synthetic peptides have a wide range of clinical effects. Of particular interest are peptides based on adrenocorticotropic hormone (ACTH) both as already used and as potential drugs for preventing consequences of cerebral ischemia. However, it is necessary to study influence of the peptide on the brain cells under normal physiological conditions, including understanding the risks of their use. Here, we used high-throughput RNA sequencing (RNA-Seq) to identify differentially expressed genes (DEGs…

  59. 70.

    Stavchanskiĭ VV, Tvorogova TV, Botsina AIu, Skvortsova VI, et al. · Molekuliarnaia biologiia · 2011 · PMID 22295573

    Neurotrophins regulate key function of nervous tissue cells. Analysis of neurotrophins mRNA expression is an appropriate tool to assess therapeutic efficiency of the anti-stroke drugs. We have analyzed the effect of synthetic peptide semax and its C-terminal Pro-Gly-Pro tripeptide upon mRNAs expression of neurotrophins Ngf, Bdrf, Nt-3 and their receptors TrkA, TrkB, TrkC, p75 in rat frontal lobes, hippocampus and cerebellum after bilateral common carotid artery occlusion. The animals were decapi…

  60. 71.

    Stavchanskiĭ VV, Tvorogova TV, Botsina AIu, Limborskaia SA, et al. · Molekuliarnaia biologiia · 2013 · PMID 23888777

    Vascular endothelial growth factor (VEGFA) is a hypoxia-inducible signal glycoprotein. VEGFA causes vascular endothelial cell growth and proliferation, that leads to the regeneration of vascular network in brain regions damaged by ischemia. However, this protein is involved in processes of inflammation and edema in early stages of ischemia. Synthetic peptide semax shows neuroprotective and anti-inflammatory properties and is actively used in the treatment of ischemia.We have previously shown tha…

  61. 72.

    Grigorjeva ME, Lyapina LA · Bulletin of experimental biology and medicine · 2010 · PMID 21113455

    The effects of semax on anticoagulant, fibrinolytic, and platelet components of the anticoagulation system were studied on albino rats under conditions of acute and chronic immobilization stress. Semax exhibited a protective antistress effect after repeated intranasal administration under conditions of hypercoagulation developing in response to immobilization stress of different degree. The effect manifested in stimulation of the anticoagulation system.

  62. 73.

    Storozhevykh TP, Tukhbatova GR, Senilova YE, Pinelis VG, et al. · Bulletin of experimental biology and medicine · 2007 · PMID 18239779

    Semax (100 microM) and its Pro-Gly-Pro fragment (20 and 100 microM) delayed the development of calcium dysregulation and reduction of the mitochondrial potential in cultured cerebellar granule cells under conditions of glutamate neurotoxicity. Incubation with these peptides improved neuronal survival by on average 30%. The neuroprotective effect of semax in cerebral ischemia/hypoxia can be due to improvement of mitochondrial resistance to "calcium" stress.

  63. 74.

    Safarova ER, Shram SI, Grivennikov IA, Myasoedov NF · Bulletin of experimental biology and medicine · 2002 · PMID 12124658

    Trophic characteristics of neuroprotectors cerebrolysin and semax were evaluated by their capacity to induce differentiation and improve survival of cultured rat pheochromocytoma (PC12) cells. Morphological signs of cell differentiation (enlargement and formation of processes) were seen 24 h after addition of cerebrolysin into culture medium. Cerebrolysin improved survival of PC12 cells in serum-free medium. In a concentration of 100 microg/ml cerebrolysin decreased the content of apoptotic cell…

  64. 75.

    Agapova TY, Agniullin YV, Silachev DN, Shadrina MI, et al. · Doklady. Biochemistry and biophysics · 2007 · PMID 18274453

  65. 76.

    Levitskaia NG, Vilenskiĭ DA, Sebentsova EA, Anreeva LA, et al. · Izvestiia Akademii nauk. Seriia biologicheskaia · 2010 · PMID 20387390

    The effects of the adrenocorticotropic hormone (ACTH(4-10)) analog, Semax (MEHFPGP), on the level of anxiety and depression in white rats have been studied in the normal state and against the background of cholecystokinin-tetrapeptide (CCK-4) action. Semax was injected intranasally in doses of 50 and 500 microg/kg 15 min before the testing. CCK-4 was administered intraperitoneally in a dose of 400 microg/kg 40 min before the testing. The level of anxiety was estimated in the elevated plus-maze t…

  66. 77.

    Kolacheva AA, Ugrumov MV · Acta naturae · 2021 · PMID 34707903

    Degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease begins from the axonal terminals in the striatum and, then, in retrograde fashion, progresses to the cell bodies in the substantia nigra. Investigation of the dynamics of axonal terminal degeneration may help in the identification of new targets for neuroprotective treatment and be used as a tool for testing potential drugs. We have shown that the degeneration rate of dopaminergic axonal terminals changes over time, and th…

  67. 78.

    Radchenko AI, Kuzubova EV, Apostol AA, Mitkevich VA, et al. · Acta naturae · 2025 · PMID 41479572

    Alzheimer's disease, first described over a century ago, is currently among the most common neurodegenerative diseases whose significance is increasingly growing with the aging of populations. Throughout the entire period of its study, no remedies have been found that would be effective in treating - or at least significantly slowing - the pathological process, while being sufficiently safe. In this regard, significant attention is paid to the development and application of natural peptide drugs…

  68. 79.

    Zhuikova SE, Smirnova EA, Bakaeva ZV, Samonina GE, et al. · Bulletin of experimental biology and medicine · 2000 · PMID 11177268

    The ACTH(4-7)analogue Semax administered intraperitoneally in a dose of 50 microg/kg 1 h before exposure to ulcerogenic factors (ethanol, water immersion immobilization stress) protected gastric mucosa from damage. Postoperative treatment with Semax for 5 days after application of glacial acetic acid on the mucosa prevented acetic acid-induced ulcers and promoted their healing. The antiulcer effects of Semax in the studied dose were comparable with those of tripeptide Pro-Gly-Pro in a dose of 1…

  69. 80.

    Shadrina MI, Dolotov OV, Grivennikov IA, Slominsky PA, et al. · Neuroscience letters · 2001 · PMID 11457573

    The proliferation, differentiation and survival of neuronal and glial cells are affected by a number of neurotrophic factors, such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and others. In a previous study, we observed the effects of 'Semax' (Met-Glu-His-Phe-Pro-Gly-Pro), the physiologically active analogue of adrenocorticotropic hormone(4--10), on neuronal cell survival in vitro. We hypothesized that these effects may be mediated by the regulation of expression of so…

  70. 81.

    Ivanikov IO, Brekhova ME, Samonina GE, Myasoedov NF, et al. · Bulletin of experimental biology and medicine · 2002 · PMID 12459874

    Experiments used is combination with traditional preparations (omeprasole, de-nol, and solcoseril), Semax peptide (Met-Glu-His-Phe-Pro-Gly-Pro) possessing nootropic and neuroprotective activity significantly promoted ulcer healing in patients with refractory peptic ulcers. On day 14 of treatment ulcer healing was observed in 89.5% patients receiving intranasal Semax (1% solution, 2-4 drops 3 times a day for 10 days) vs. 30.8% in the control group. Clinical studies of antiulcer activity of Semax…

  71. 82.

    Dmitrieva VG, Dergunova LV, Povarova OV, Skvortsova VI, et al. · Doklady. Biochemistry and biophysics · 2008 · PMID 19024553

  72. 83.

    Dolotov OV, Zolotarev IuA, Dorokhova EM, Andreeva LA, et al. · Bioorganicheskaia khimiia · 2004 · PMID 15344653

    The binding characteristics of the peptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) to plasma membranes of basal nuclei of the rat forebrain and the dynamics of its degradation during its incubation with these membranes were studied. Binding of the homogeneously labeled [G-3H]Semax was shown to be time-dependent, specific, and reversible. Specific binding of the heptapeptide depended on calcium ions and was characterized by the dissociation constant of the ligand-receptor complex Kd = 2.41 +/- 1.02 x…

  73. 84.

    Zhuikova SE, Sergeev VI, Samonina GE, Myasoedov NF · Bulletin of experimental biology and medicine · 2002 · PMID 12447470

    Intraperitoneal injection of Semax (synthetic analogue of ACTH4-7, MEHFPGP) in a dose of 50 mg/kg produced a protective effect on rats with experimental indomethacin-induced ulcers. Experiments on narcotized rats showed that Semax in the studied dose had no effect on basal blood flow in the stomach, but prevented reduction of blood flow induced by indomethacin. The antiulcer effect of Semax is probably related to improvement of blood flow in the gastric wall disturbed by indomethacin.

  74. 85.

    Potaman VN, Alfeeva LY, Kamensky AA, Levitzkaya NG, et al. · Biochemical and biophysical research communications · 1991 · PMID 1851003

    Degradation of a regulatory peptide ACTH(4-10) and its synthetic analog semax in rat blood and serum was studied using high-performance liquid chromatography. About one third to one half of the serum degrading activity could be ascribed to bestatin-sensitive aminopeptidase which cleaved first and second N-terminal residues Met and Glu producing relatively stable intermediates. Comparable areas under the degradation/accumulation curves for intact peptides and intermediates implied that the latter…

  75. 86.

    Zolotarev YA, Dolotov OV, Inozemtseva LS, Dadayan AK, et al. · Amino acids · 2006 · PMID 16773243

    Here a new approach of the elucidation of paths of proteolytic biodegradation of physiologically active peptides, based on the use of a peptide with isotopic label at all amino acid residues and the enrichment of HPLC samples with unlabeled peptide fragments in UV-detectable concentration, has been proposed. The method has been applied for the investigation of degradation dynamics of the neuroactive heptapeptide MEHFPGP (Semax) in the presence of plasma membranes, and cultures of glial and neuro…

  76. 87.

    Ashmarin IP, Samonina GE, Lyapina LA, Kamenskii AA, et al. · Pathophysiology : the official journal of the International Society for Pathophysiology · 2005 · PMID 15837162

    The present concept of relative instability of regulatory peptides (RPs) in organisms must be amended. The recently characterized family of glyprolines and some other prolyl-glycyl-proline (PGP)-containing oligopeptides show the stability quite comparable with those of major pharmacological preparations. The ability of glyprolines to pass gastro-enteric tract barriers opens ways to per-oral administration of this new group of drugs such as semax, selank and their fragments. The most interesting…

  77. 88.

    Medvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, et al. · Journal of molecular neuroscience : MN · 2013 · PMID 22772900

    The synthetic peptide Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is used successfully in acute stroke therapy. In spite of numerous studies on the subject, many aspects of the neuroprotective effects of the peptide remain unknown. We studied the action of Semax and its C-terminal tripeptide Pro-Gly-Pro on the expression of the VEGF gene family (Vegf-a, Vegf-b, Vegf-c, Vegf-d, and Plgf) and their receptors (Vegfr-1, Vegfr-2, and Vegfr-3) in the frontoparietal cortex region of the rat brain at 3, 24, and…

  78. 89.

    Bashkatova VG, Koshelev VB, Fadyukova OE, Alexeev AA, et al. · Brain research · 2001 · PMID 11245825

    This work investigates whether nitric oxide production and lipid peroxidation contribute to the pathophysiology of ischemia and whether glycine and a novel Russian compound, Semax are neuroprotective via a mechanism involving the regulation nitric oxide (NO) and lipid peroxidation. In brief, nitric oxide and indices of lipid peroxidation were elevated following global ischemia. While glycine proved ineffective in reducing NO levels or ameliorating the neurological deficits following global ische…

  79. 90.

    Vilenskiĭ DA, Levitskaia NG, Andreeva LA, Alfeeva LIu, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2007 · PMID 17850024

    Effects of chronic intranasal administration of ACTH(4-10) analog Semax (MEHFPGP) on exploratory activity, anxiety level, and depression-like behaviour were studied in white rats. The peptide was injected daily in dose 0.05 mg/kg during 10 or 14 days. It was shown that chronic Semax administration at 1-2 weeks induced anxiolytic and antidepressant effects but did not influenced the exploratory activity in non-stressogenic environment. The Semax effects may be the results of activation of the bra…

  80. 91.

    Shypshyna MS, Veselovsky NS, Myasoedov NF, Shram SI, et al. · Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) · 2015 · PMID 26552305

    The influence of long-term culturing (12 days in vitro) of dorsal root ganglion (DRG) and dorsal horn (DH) neurons with peptide Semax on the level of synaptic activity at co-cultures, as well as short-term plasticity in sensory synapses were studied. It has been shown that neuronal culturing with peptide at concentrations of 10 and 100 µM led to increasing the frequency of spontaneous glutamatergic postsynaptic currents in DH neurons to 71.7 ± 1.8% and 93.9 ± 3.1% (n = 6; P < 0.001); Semax has a…

  81. 92.

    Svishcheva MV, Mishina YS, Medvedeva OA, Bobyntsev II, et al. · Bulletin of experimental biology and medicine · 2021 · PMID 33459919

    We studied the effect of intraperitoneal administration ACTH

  82. 93.

    Agapova TIu, Agniullin IaV, Silachev DN, Shadrina MI, et al. · Molekuliarnaia genetika, mikrobiologiia i virusologiia · 2008 · PMID 18756821

    Semax is a synthetic peptide, which consists of the N-terminal adrenocorticotropic hormone fragment (4-7) (ACTH4-7) and C-terminal Pro-Gly-Pro peptide. Semax promotes neuron survival in hypoxia, increases selective attention and memory storage. It was shown that this synthetic peptide exerted a number of gene expressions, especially brain derived neurotrophic factor gene (Bdnf) and nerve growth factor gene (Ngf). Temporary dynamics of Bdnf and Ngf ex- pression in rat hippocampus and frontal cort…

  83. 94.

    Safarova ER, Shram SI, Zolotarev YA, Myasoedov NF · Bulletin of experimental biology and medicine · 2003 · PMID 12802399

    We studied the effects of Semax (antiinsulin peptide with neuroprotective effect) on the survival of cultured rat pheochromocytoma cell after oxidative stress induced by short-term incubation with hydrogen peroxide. Studies with fluorescent dyes propidium iodide and Hoechst 33258 showed that cell incubation with hydrogen peroxide led to the formation of damaged cells with characteristic signs of necrosis. Semax dose-dependently reduced the number of cells damaged by oxidative stress. The efficie…

  84. 95.

    Volodina MA, Sebentsova EA, Glazova NY, Manchenko DM, et al. · Acta naturae · 2012 · PMID 22708068

    Adverse experience during the early postnatal period induces negative alterations in physiological and neurobiological functions, resulting in long-term disorder in animal behavior. The aim of the present work was to study the long-lasting effects of chronic neonatal stress in white rats and to estimate the possibility of their correction using Semax, an analogue of ACTH fragment (4-10). Early neonatal isolation was used as a model of early-life stress. Rat pups were separated from their mothers…

  85. 96.

    Gavrilova SA, Markov MA, Berdalin AB, Kurenkova AD, et al. · Bulletin of experimental biology and medicine · 2017 · PMID 28948544

    The effect of peptide Semax on remodeling of cardiac sympathetic innervation was examined in rats with experimental myocardial infarction. In 28 days after ischemia/reperfusion injury, Semax diminished the growth of sympathetic innervation of ventricular septum, although it produced no effect on the density of β

  86. 97.

    Shevchenko KV, Nagaev IY, Andreeva LA, Alfeeva LY, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2013 · PMID 23821053

  87. 98.

    Severyanova LA, Kryukov AA, Plotnikov DV, Dolgintsev ME · Bulletin of experimental biology and medicine · 2020 · PMID 33263853

    The effects of peptide ACTH4-7-PGP (Semax) were studied in 12 min after its intraperitoneal (in doses of 5, 15, 50, 150, and 450 μg/kg) or intracerebroventricular (in doses of 16, 40, and 400 pg) administration to rats with different types of pain and pain-induced behavior. It was found that the peptide increased pain sensitivity and induced avoidance behavior during thermal stimulation ("hot plate" test), but had an analgesic effect (more pronounced after central administration) and weakened em…

  88. 99.

    Charleston-Villalobos S, Cortés-Rubiano S, González-Camarena R, Chi-Lem G, et al. · Medical & biological engineering & computing · 2004 · PMID 15503962

    As respiratory sounds contain mechanical and clinical pulmonary information, technical efforts have been devoted during the past decades to analysing, processing and visualising them. The aim of this work was to evaluate deterministic interpolating functions to generate surface respiratory acoustic thoracic images (RATHIs), based on multiple acoustic sensors. Lung sounds were acquired from healthy subjects through a 5 x 5 microphone array on the anterior and posterior thoracic surfaces. The perf…

  89. 100.

    Gavrilova SA, Golubeva AV, Lipina TV, Fominykh ES, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2006 · PMID 17385423

    Semax, a member of ACTH-derived peptides family, was used in treatment of ischemic stroke in patients. It decreased neurological deficiency and reduced NO hyperproduction in the rat brain caused by acute cerebral hypoperfusion. We suggest that semax is also capable of protecting the rat heart from ischemic damage 28 days after myocardial infarction (MI) induced by left descendent coronary artery occlusion. Semax (150 microg/kg) was given i. p. in the operating day twice: 15 min and 2 hours after…

  90. 101.

    Inozemtsev AN, Agapitova AE, Bokieva SB, Levitskaya NG, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2013 · PMID 23479006

  91. 102.

    Shilova OB, Markina NV, Perepelkina OV, Gichenok IV, et al. · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2004 · PMID 15658043

    DBA/2, CBA mice, and their F1 hybrids (first series) and 101/HY and C3H mice (second series) were injected as neonates (2-7 days of life) with Semax (sc., 7 microg per animal). Semax is a peptide analogue of ACHT4-10 fragment which is resistant to degradation. The common feature of remote effects of both Semax and saline injections was the set of changes in the open-field behavior in adult (2.5- to 3-month-old) animals as compared to intact mice. Unexpectedly, the neonatal saline injections indu…

  92. 103.

    Shevchenko KV, Khrapko AP, Schwets VI, Myasoyedov NF · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2009 · PMID 20170058

  93. 104.

    Shakova FM, Kirova YI, Silachev DN, Romanova GA, et al. · Brain sciences · 2021 · PMID 33806692

    The pharmacological induction and activation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), a key regulator of ischemic brain tolerance, is a promising direction in neuroprotective therapy. Pharmacological agents with known abilities to modulate cerebral PGC-1α are scarce. This study focused on the potential PGC-1α-modulating activity of Mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) and Semax (ACTH

  94. 105.

    Asmarin IP, Nezavibat'ko VN, Miasoedov NF, Kamenskiĭ AA, et al. · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 1997 · PMID 9173745

    Semax is one of the rare analogues of regulatory peptides which underwent all stages from fundamental investigations to practical usage. It has been demonstrated that this peptide is capable to stimulate operative memory and attention, to increase resistance to hypoxia and to improve brain circulation in experimental animals and human beings over prolonged period (20-24 h after intranasal administration in doses 0.015-0.050 mg/kg). Semax significantly improves memory and attention in healthy men…

  95. 106.

    Zhuĭkova SE, Badmaeva KE, Samonina GE, Plesskaia LG · Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology · 2003 · PMID 14653248

    Previously we showed that peptides PGP, PG, GP and semax have protective anti-ulcer properties using different models of ulcerogenesis. Semax (MEHFPGP) is a nootropic analogue of adrenocorticotropin 4-7 stabilized by PGP in the C-terminal region. In this study we examined the impact of these peptides on the development and healing of acetic ulcers in rats. The histomorphological and dynamical characteristics of acetic ulcers are most similar to human chronic ulcers. All the peptides were shown t…

  96. 107.

    Levitskaia NG, Sebentsova EA, Andreeva LA, Alfeeva LIu, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2002 · PMID 12587264

    Effects of an ACTH (4-10) analogue Semax (MEHFPGP) on behaviour of white rats with MPTP-induced disturbances of brain DA-system have been studied. It was shown that MPTP administration (25 mg/kg) reduced motor activity and auhmented the anxiety level in rats. Semax administration (daily intranasal 0.2 mg/kg) attenuated behaviour disturbances induced by neurotoxin. The observed protective action of Semax in rats with MFTP-induced DA system disturbances may be due to both its modulating influence…

  97. 108.

    Grigoriev VV, Andreeva LA, Zamoyski VL, Shevchenko VP, et al. · Doklady. Biochemistry and biophysics · 2015 · PMID 25772990

  98. 109.

    Silachev DN, Shram SI, Shakova FM, Romanova GA, et al. · Neuroscience and behavioral physiology · 2009 · PMID 19779827

    Photochemically induced thrombosis of blood vessels in the prefrontal cortex in rats was shown to lead to ischemic infarcts in the lesion zone. Bilateral ischemic lesioning of the prefrontal cortex degraded measures of spatial memory when animals were tested in a Morris water maze with an invisible platform 20-24 days after surgery. Chronic intranasal administration of the peptide Met-Glu-His-Phe-Pro-Gly-Pro (Semax), a synthetic analog of ACTH(4-7), at a dose of 250 microg/kg/day during the firs…

  99. 110.

    Ivanov AV, Bobyntsev II, Shepeleva OM, Kryukov AA, et al. · Bulletin of experimental biology and medicine · 2017 · PMID 28577097

    We studied the effect of intraperitoneal administration of peptide ACTG

  100. 111.

    Kopylova GN, Smirnova EA, Sanzhieva LTs, Umarova BA, et al. · Bulletin of experimental biology and medicine · 2003 · PMID 14968154

    One-hour immobilization stress considerably disturbed microcirculation in the mesentery: blood flow in small mesenteric vessels decreased or stopped and numerous hemorrhages appeared. Lymphatic vessels lost spontaneous activity and did not respond to norepinephrine. Administration of Semax and glyprolines 1 h before stress decreased the severity of stress-induced microcirculatory disturbances. PGP and GP were most effective in this respect.

  101. 112.

    Koroleva MV, Meĭzerov EE, Nezavibat'ko VN, Kamenskiĭ AA, et al. · Biulleten' eksperimental'noi biologii i meditsiny · 1996 · PMID 8679991

  102. 113.

    Maev IV, Dicheva DT · Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology · 2003 · PMID 12875006

    We showed antisecretory effects of peptides of PGP, semax and a new pancreatic hormone, amylin, on the model of continuous stomach perfusion with the registration of pH, PCO2 as well as the determination of the amount of pepsinogen in the stomach perfusate. The intraperitoneal introduction of these peptides in the doses that proved to have an apparent anti-ulcer effect caused a decrease of both basal production of hydrochloric acid in the stomach and production caused by the irritation of the va…

  103. 114.

    Alekseeva GV, Bottaev NA, Goroshkova VV · Anesteziologiia i reanimatologiia · 1999 · PMID 10199046

    Effect of a neuropeptide semax is studied in 73 patients with various symptoms of posthypoxic encephalopathy in remote period. Fourteen of these patients developed a persistent vegetative state. The therapy was effective in patients with mnestic disorders; the drug effect was potentiated by an adaptogen oxiterm and by supraorbital electrophoresis. In some cases EEG showed episodes of paroxysmal activity after semax injection, and therefore, the first injection should be carried out with monitori…

  104. 115.

    Filippenkov IB, Stavchansky VV, Glazova NY, Sebentsova EA, et al. · International journal of molecular sciences · 2021 · PMID 34576218

    Natural melanocortins (MCs) have been used in the successful development of drugs with neuroprotective properties. Here, we studied the behavioral effects and molecular genetic mechanisms of two synthetic MC derivatives-ACTH(4-7)PGP (Semax) and ACTH(6-9)PGP under normal and acute restraint stress (ARS) conditions. Administration of Semax or ACTH(6-9)PGP (100 μg/kg) to rats 30 min before ARS attenuated ARS-induced behavioral alterations. Using high-throughput RNA sequencing (RNA-Seq), we identifi…

  105. 116.

    Student IOHP, Professor SYSMPD · Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti · 2021 · PMID 34418946

    The article presents a study of the effect of a modified fragment of neuropeptide Y (H-L-Ile-L-Asn-L-Leu-L-Nle-L-Ser- L-Arg-L-Asn-L-Arg-L-Tyr-NH2) named nonapeptide NP9 on the memory phases and extrapolation escape of animals. The study was performed in the passive avoidance test with intact animals, scopolamine-treated animals, and the extrapolation escape task. NP9 was investigated in the dose range of 0.04-0.4 mg/kg with a single intranasal administration. The comparison drug used peptide noo…

  106. 117.

    Novosadova EV, Arsenyeva EL, Antonov SA, Vanyushina YN, et al. · Biochemistry. Biokhimiia · 2019 · PMID 31760919

    Development of therapeutic preparations involves several steps, starting with the synthesis of chemical compounds and testing them in different models for selecting the most effective and safest ones to clinical trials and introduction into medical practice. Cultured animal cells (both primary and transformed) are commonly used as models for compound screening. However, cell models display a number of disadvantages, including insufficient standardization (primary cells) and disruption of cell ge…

  107. 118.

    Koroleva MV, Meĭzerov EE, Nezavibat'ko VN, Kamenskiĭ AA, et al. · Biulleten' eksperimental'noi biologii i meditsiny · 1996 · PMID 8998343

  108. 119.

    Gorbacheva AM, Berdalin AB, Stulova AN, Nikogosova AD, et al. · Bulletin of experimental biology and medicine · 2016 · PMID 27591879

    Activation of the sympathetic nervous system aggravates the course of myocardial infarction. Semax peptide moderated the degree of this activation and prevented the increase in the density of sympathetic endings in rat caudal artery in 28 days after ischemia or ischemia/reperfusion. The peptide reduced the density of α-adrenoreceptors in the caudal artery of rats with myocardial infarction. Semax produced no effect on β-adrenoreceptors in both experimental models. The experiments on isolated seg…

  109. 120.

    Bezuglov VV, Gretskaia NM, Vasil'eva TM, Petrukhina GN, et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2014 · PMID 25102733

    The influence two original derivatives of a therapeutically important peptide, bearing arachidonic acid residue with semax and proglyprol, upon platelet aggregation have been studied in vitro. It is established that both derivatives, in contrast to the parent peptide, possess moderate anti-aggregant properties and produce a dose-dependent decrease in the interplatelet interaction induced by ADP, epinephrine, and arachidonic acid within the concentration range of 0.018 - 1.8 mM. This activity was…

  110. 121.

    Iakovleva EV, Kuzenkov VS, Fedorov VN, Skvortsova VI, et al. · Biulleten' eksperimental'noi biologii i meditsiny · 1999 · PMID 11188738

  111. 122.

    Arushanian EB, Popov AV · Eksperimental'naia i klinicheskaia farmakologiia · 2009 · PMID 19441725

    Peptide drug semax with nootropic properties did not change the heart rate variability in rats in the morning, but produced a significant optimizing action and attenuated the stress-induced sympathetic influences on the heart in the evening. It is suggested that semax has a chronotropic activity, which may participate in realization of the specific drug action.

  112. 123.

    Astashkin EI, Petrov EA, Bespalova Y, Glezer MG, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2001 · PMID 12918351

  113. 124.

    Sebentsova EA, Glazova NIu, Levitskaia NG, Andreeva LA, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2005 · PMID 15835535

    Long-lasting behavioural effects of chronic administration of synthetic ACT(4-10) analogue Semax (MEHFPGP) during early neonatal life were studied. The peptide was injected daily intraperitoneally in dose 0.05 mg/kg during the first, second or second-third weeks of postnatal development. It was shown that the peptide injections during the first week lead to a decrease and during second or second-third weeks--to an increase of exploratory activity in 4-8-week aged rats. Furthermore, the peptide a…

  114. 125.

    Kobylyanskii AG, Zolotarev YA, Andreeva LA, Grivennikov IA, et al. · Bulletin of experimental biology and medicine · 2017 · PMID 29063333

    We studied the effects of peptide drugs (HLDF-6, PGP, RPGP, and PGLP) and peptide pharmaceutical products (Semax, Selank, and thyroliberin) on proliferation and survival of mouse embryonic stem cells and their derivatives. Differentiation of mouse embryonic stem cells into neuronal precursors was evaluated. PGP and PGLP in concentrations of 10 and 0.1 μM, respectively, had little, but significant inhibitory effect on proliferative activity of cells. These peptides in concentrations of 10 and 0.1…

  115. 126.

    Cherkasova KA, Lyapina LA, Ashmarin IP · Bulletin of experimental biology and medicine · 2001 · PMID 11687836

    Intranasal administration of Semax, peptide Pro-Gly-Pro, and a mixture of peptides Pro-Gly+Gly-Pro to rats for 5 days enhanced anticoagulant and fibrinolytic potential of the plasma (total fibrinolytic activity and plasmin and plasminogen activator activities) and decreased antiplasmin concentration. Semax and Pro-Gly-Pro decreased the weight of thrombi during experimental thrombosis.

  116. 127.

    Bezuglov VV, Gretskaia NM, Blazhenova AV, Adrianova EL, et al. · Bioorganicheskaia khimiia · 2006 · PMID 16808168

    N-Arachidonoyl (AA) derivatives of amino acids (glycine, phenylalanine, proline, valine, gamma-amino butyric acid (GABA), dihydroxyphenylalanine, tyrosine, tryptophan, and alanine) and peptides (Semax, MEHFPGP, and PGP) were synthesized in order to study the biological properties of acylamino acids. The mass spectra of all the compounds at atmospheric pressure electrospray ionization display the most intense peaks of protonated molecular ions; the detection limits for these compounds are 10 fmol…

  117. 128.

    Arushanian EB, Popov AV · Eksperimental'naia i klinicheskaia farmakologiia · 2008 · PMID 18488900

    The chronic administration of nootropic drug Semax, a peptide analog of ACTH (4-10), normalized the circadian locomotor rhythm in rats (with an increase in its amplitude, a shift in the acrophase, and a change of the spectral characteristics) and reduced the integral chronobiological index. It is suggested that the rhythm-synchronizing chronotropic activity may be a part of the specific effect of this cognitive enhancer.

  118. 129.

    Kurysheva NI, Shpak AA, Ioĭleva EE, Galanter LI, et al. · Vestnik oftalmologii · 2001 · PMID 11569188

    A complex of neuroprotective therapy, including a new Russian neuropeptide semax, was used in the treatment of glaucoma patients with normalized ophthalmic tone. Electrophysiological and computer methods of examination demonstrated the advantages of new therapy over traditional neuroprotective treatment for glaucoma. The efficiency is due to pathogenetic activity of semax possessing both neuroprotective and neurotrophic effects.

  119. 130.

    Gusev EI, Skvortsova VI, Chukanova EI · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2005 · PMID 15792140

    One hundred and eighty-seven patients with different stages of cerebrovascular insufficiency (CI) have been examined. A diagnosis of CI was based on the results of neurological and neuropsychological study, ultrasonic dopplerography, rheo- and encephalography, electrocardiography, brain MRI and eyegrounds examination. Neurological scales were used for neurological status assessment and further data processing. The study aimed at evaluation of tolerability and clinical efficacy of the medication…

  120. 131.

    Miasoedova NF, Skvortsova VI, Nasonov EL, Zhuravleva EIu, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 1999 · PMID 10358912

    Semax is the first domestic nootropic drug of an unexhausted type from the group of neuropeptides. In experimental studies it showed angioprotective, antihypoxic and neurotrophic activity in the doses 100-150 micrograms/kg. A combined clinical-electrophysiologic study revealed its high efficiency in acute ischemic stroke. A clinical trial was performed of immunobiochemical mechanisms of neuroprotective properties of Semax in acute period of ischemic stroke. A retrospective comparative clinicoimm…

  121. 132.

    Potaman VN, Alfeeva LY, Kamensky AA, Nezavibatko VN · Peptides · 1993 · PMID 8392718

    Degradation of the behaviorally active peptide ACTH/MSH(4-10) and its synthetic analog semax was studied in serum in the presence of several specific peptidase inhibitors. Bestatin and puromycin were used to inhibit aminopeptidase activity, lisinopril for angiotensin-converting enzyme, phosphoramidon for neutral endopeptidase 24.11, and Z-Pro-prolinal for prolyl endopeptidase. Bestatin inhibited up to 66%, puromycin about 33%, and lisinopril about 15% of total degrading activity against both ACT…

  122. 133.

    Timoshenko TV, Poletaeva II, Pavlova GV, Revishchin AV · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2009 · PMID 19341092

  123. 134.

    Boyarshinova OS, Revishchin AV, Poletaeva II, Korochkin LI · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2004 · PMID 15354819

  124. 135.

    Vanhee C, Francotte A, Janvier S, Deconinck E · Drug testing and analysis · 2020 · PMID 31667971

    At the end of 2017 and 2018 two different unknown suspicious preparations were encountered and were subjected to a plethora of different analyses in order to identify, if present, any bioactive compound. It turned out that these samples contained the assumedly cognitive enhancing research peptides Selank and Semax, which, to our knowledge, have not completed any clinical trials. Moreover, an online search, excluding the dark web, demonstrated that these kinds of nootropic research peptides are f…

  125. 136.

    Iasnetsov VV, Chertorizhskiĭ EA, Belyĭ PA, Bespalova ZhD, et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2015 · PMID 25826866

    A new mixture of tripeptides (NMT: H-Lys-Asp-Glu-OH, H-Asp-Glu-Pro-OH, H-Asp-Glu-Arg-OH) in doses of 150 and 300 mg/kg per day produces clearly pronounced neuroprotective effect in rats with brain ischemia and decreases neurologic deficiency 1.1 times more effectively than reference drug semax. NMT (10, 50 and 150 mg/kg) had marked antihypoxic effect on mice in hermetic and altitude chamber. NMT in doses of 10 and 50 mg/kg was more effective than semax in hermetic chamber (1.3 and 1.5 times, res…

  126. 137.

    Eremin KO, Saransaari P, Oja S, Raevskiĭ KS · Eksperimental'naia i klinicheskaia farmakologiia · 2004 · PMID 15188751

    The synthetic peptide semax (a fragment of ACTH 4-7 Pro-Gly-Pro) enhances the release of extracell dopamine (DA) induced by D-amphetamine (5 mg/kg) in the striatum of Spraig-Dowley (SD) rats and increases the locomotor activity stimulated by D-amphetamine (2 mg/kg) in C57/BL6 mice. The basal content of DA, 3,4-dihydroxyphenylacetic acid (DHPAA), and homovanillic acid (HVA) in dialysate of SD rats was 0.5-1.0, 996 +/- 25, and 761 +/- 37 pmole/ml, respectively (n = 7). D-amphetamine (5 mg/kg) indu…

  127. 138.

    Ivanova DM, Levitskaya NG, Andreeva LA, Alfeeva LY, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2003 · PMID 12712960

  128. 139.

    Bakhmet AA, Koplik EV · Bulletin of experimental biology and medicine · 2012 · PMID 23113251

    We studied the effect of antistress peptide Semax, an ACTH4-10 analogue, on the cellular composition of spleen lymphoid structures in Wistar rats with different stress tolerance in the course of post-stress recovery (days 1, 3, 14, and 30). Preliminary administration of Semax alleviates stress-induced proliferation of macrophages and destructive processes in functionally active zones of the rat spleen on days 1, 3, and 14 after the stress exposure, which attests to its capacity to reduce the adv…

  129. 140.

    Astashkin EI, Bespalova YuB, Grivennikov IA, Smirnov ON, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2000 · PMID 11103338

  130. 141.

    Stavchansky VV, Yuzhakov VV, Sevan'kaeva LE, Fomina NK, Koretskaya AE, Denisova AE, Mozgovoy IV, Gubsky LV, Filippenkov IB, Myasoedov NF, Limborska SA, Dergunova LV. · 2024 · PMID 38534749

    Stroke remains the second leading cause of death worldwide. The development of new therapeutic agents focused on restoring vascular function and neuroprotection of viable tissues is required. In this study the neuroprotective activity of melanocortin-like ACTH(4-7)PGP and ACTH(6-9)PGP peptides was investigated in rat brain at 24 h after transient middle cerebral artery occlusion (tMCAO). The severity of ischemic damage, changes in the proliferative activity of neuroglial cells and vascularizatio…

  131. 142.

    Dergunova LV, Filippenkov IB, Limborska SA, Myasoedov NF. · 2023 · PMID 37239313

    Ischemic stroke continues to be one of the leading causes of death and disability in the adult population worldwide. The currently used pharmacological methods for the treatment of ischemic stroke are not effective enough and require the search for new tools and approaches to identify therapeutic targets and potential neuroprotectors. Today, in the development of neuroprotective drugs for the treatment of stroke, special attention is paid to peptides. Namely, peptide action is aimed at blocking…

  132. 143.

    Deigin VI, Poluektova EA, Beniashvili AG, Kozin SA, Poluektov YM. · 2022 · PMID 35456550

    Peptides are low-molecular-weight substances that participate in numerous important physiological functions, such as human growth and development, stress, regulation of the emotional state, sexual behavior, and immune responses. Their mechanisms of action are based on receptor-ligand interactions, which result in highly selective effects. These properties and low toxicity enable them to be considered potent drugs. Peptide preparations became possible at the beginning of the 20th century after a…

  133. 144.

    Markov DD, Dolotov OV, Grivennikov IA. · 2023 · PMID 37047638

    Major depression is one of the most prevalent mental disorders, causing significant human suffering and socioeconomic loss. Since conventional antidepressants are not sufficiently effective, there is an urgent need to develop new antidepressant medications. Despite marked advances in the neurobiology of depression, the etiology and pathophysiology of this disease remain poorly understood. Classical and newer hypotheses of depression suggest that an imbalance of brain monoamines, dysregulation of…

  134. 145.

    Asadullah A, Bajamal AH, Parenrengi MA, Turchan A, Utomo B, Sudiana IK, Subagio EA. · 2023 · PMID 41179234

    <h4>Background</h4>Spinal cord injury (SCI) is a damage to the spinal cord caused mainly by trauma resulting in major motor, sensory and autonomic dysfunctions. Its final neurological outcome is determined by both primary and secondary injury processes. A key component of secondary injury mechanisms after initial trauma is neuroinflammation. A neuroprotective compound, ACTH <sub>4-10</sub>Pro <sup>8</sup>-Gly <sup>9</sup>-Pro <sup>10</sup> (ACTH <sub>4-10</sub>) also known as semax, has shown ne…

  135. 146.

    Kudina O, Shtrygol S, Larjanovska Y. · 2023 · PMID 37161509

    <h4>Objectives</h4>Aim of the current study was to evaluate the stress-protective effect of oligopeptides-homologues of the adrenocorticotropic hormone (ACTH) fragment 15-18 on morphogenetic signs of stress reaction of the adrenal glands under acute cold exposure (CE) in rats.<h4>Materials and methods</h4>The acute cold stress was reproduced by placing random-bred male rats in a freezer at a temperature of -18°C for 2 hours. The peptides-homologous of ACTH<sub>15-18</sub> acetyl-(D-Lys)-Lys-Arg-…

  136. 147.

    Yusef Y, Sheludchenko VM, Korzhavina AV, Kosova DV, et al. · Vestnik oftalmologii · 2026 · PMID 42885627

    Surgery for advanced stages of primary open-angle glaucoma (POAG) aims to normalize intraocular pressure (IOP). A course of physiotherapy during subsequent stages of surgical treatment may have an additional beneficial effect. The study evaluated the effect of physiotherapy in patients with glaucomatous optic neuropathy and surgically compensated IOP. This prospective cohort study included 50 patients (64 eyes) with stage II-III POAG and indications for glaucoma surgery - nonpenetrating deep scl…

Preprints (not yet peer-reviewed)

3
  1. 148.

    Asadullah A, Bajamal AH, Parenrengi MA, Turchan A, Utomo B, Sudiana IK, Subagio EA. · 2025

    Background Spinal cord injury (SCI) is a damage to the spinal cord caused mainly by trauma resulting in major motor, sensory and autonomic dysfunctions. Its final neurological outcome is determined by both primary and secondary injury processes. A key component of secondary injury mechanisms after initial trauma is neuroinflammation. A neuroprotective compound, ACTH 4-10 Pro 8 -Gly 9 -Pro 10 (ACTH 4-10 ) also known as semax, has shown neuroprotective and anti-inflammatory properties. ACTH 4-10 h…

  2. 149.

    Asadullah A, Bajamal AH, Parenrengi MA, Turchan A, Utomo B, Sudiana IK, Subagio EA. · 2023

    <h4>Background: </h4> Spinal cord injury (SCI) is a damage to the spinal cord caused mainly by trauma resulting in major motor, sensory and autonomic dysfunctions. Its final neurological outcome is determined by both primary and secondary injury processes. A key component of secondary injury mechanisms after initial trauma is neuroinflammation. A neuroprotective compound, ACTH 4-10 Pro 8 -Gly 9 -Pro 10 (ACTH 4-10 ) also known as semax, has shown neuroprotective and anti-inflammatory properties.…

  3. 150.

    Marwaha A, Venkatakrishnan A, Varma G, Shiv S, Hollmer N, Murugadoss K, Gregg CJ, Soundararajan V. · 2026

    Semax and Selank are synthetic regulatory peptides that are not FDA-approved for human use but are marketed direct-to-consumer for cognition, mood and stress resilience. The extent of the documented use of these unapproved peptides in routine clinical care remains poorly characterized and, because neither is dispensed through regulated pathways, is largely absent from structured medication data of Electronic Health Records (EHRs). Using Large Language Model (LLM) curation of de-identified clinic…

Curated sources on file

5
  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.

Continue reading